Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Oral Dis ; 15(5): 360-5, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19371399

ABSTRACT

OBJECTIVES: To explore the association between dental erosion and gastro-oesophageal reflux disease (GORD), we used an animal model of GORD. MATERIALS AND METHODS: We performed an operation to force gastro-duodenal contents reflux in male Wistar rats, and examined the teeth in the reflux rats at 15 or 30 weeks postoperatively. Dental erosion was evaluated based on a slightly modified index from a previous report. Estimation of pH was employed in the oesophageal and gastric contents. RESULTS: Macroscopically, dental erosion was only detected in the reflux rats. Histopathologically, dentin exposure was detected in three of the seven cases after 30 weeks. Alveolar bone destruction and osteomyelitis were also noted in severe cases. The pH of the oesophageal and stomach contents was 6.93 +/- 0.15 and 3.7 +/- 0.39, respectively. CONCLUSIONS: We confirmed the relationship between dental erosion and GORD. First step of dental erosion caused by GORD is the loss of surface enamel induced by regurgitation of an acidic liquid and acidic gas. Subsequently, further destruction of dental hard tissues and tooth supporting structure is accelerated by mixed juice with gastric and duodenal contents. The reflux animal model is a useful tool to examine the mechanism of dental erosion in GORD.


Subject(s)
Disease Models, Animal , Gastroesophageal Reflux/complications , Tooth Erosion/etiology , Alveolar Bone Loss/etiology , Anastomosis, Surgical , Animals , Dental Enamel/pathology , Dentin/pathology , Esophagus/physiopathology , Esophagus/surgery , Gastroesophageal Reflux/physiopathology , Gastrointestinal Contents/chemistry , Hydrogen-Ion Concentration , Jejunum/surgery , Male , Mandibular Diseases/etiology , Molar/pathology , Osteomyelitis/etiology , Rats , Rats, Wistar , Time Factors , Tooth Erosion/classification
2.
Osteoarthritis Cartilage ; 17(7): 848-55, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19147375

ABSTRACT

OBJECTIVE: To assess changes in the health outcomes of Japanese patients before and after total hip arthroplasty (THA), and to assess the impact of THA on commonly performed postures or body positions requiring deep flexion of the hip joint such as the use of Japanese squat toilets. METHODS: Consecutive patients undergoing primary THA between July 2003 and July 2004 were eligible for the study. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the EuroQol 5D (EQ-5D) were administered at the preoperative period and two postoperative periods of 6 weeks and 6 months. The patients were also asked to rate three items regarding common activities of daily living in Japan such as squatting. Changes in scores were examined using effect size and proportion at the floor and ceiling. RESULTS: Four-hundred and fifty-one patients completed both pre- and post-THA surveys. Significant improvements in pain and physical function as measured by WOMAC and EQ-5D were evident within 6 weeks. Changes in WOMAC and EQ-5D subscale scores and scores for each item from the three time periods were highly significant (P=0.000). The effect size was 1.56 for WOMAC pain and 1.38 for physical function at 6 months. In contrast, two items (Japanese toilet and seiza) became significantly worse at the 6-week postoperative period (P=0.000) and returned to preoperative levels by the 6-month postoperative period. CONCLUSION: These results highlight the importance of evaluating culturally sensitive physical functions in addition to conventional measurements for the health outcomes of THA patients.


Subject(s)
Arthroplasty, Replacement, Hip/rehabilitation , Life Style , Quality of Life , Activities of Daily Living , Adult , Aged , Aged, 80 and over , Female , Health Status Indicators , Humans , Japan , Male , Middle Aged , Posture , Prognosis
3.
Inflamm Res ; 57(3): 126-34, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18301866

ABSTRACT

INTRODUCTION: The pathophysiology of rheumatoid arthritis (RA) includes inflammation, synoviocyte proliferation, angiogenesis, and matrix metalloproteinase-driven degradation processes. The objective of this study was to investigate a variety of structurally unrelated anticancer topoisomerase inhibiting agents as inhibitors of aspects of these disease processes involved in RA. METHOD: The topoisomerase I inhibitors camptothecin and beta-laperchone and the topoisomerase II inhibitors, etoposide, doxorubicin, plumbagin and menadione were used in this study. Crystal induced neutrophil activation was measured by luminol dependent chemiluminescence. Synoviocyte proliferation was measured by an MTT assay using HIG 82 rabbit synoviocytes in cell culture. Angiogenesis was measured using the chorioallantoic membrane of the chick embryo. Chondrocyte (culture primary cells) expression of the matrix metalloproteinases collagenase and stromelysin was measured by Northern Blot analysis. RESULTS: All agents inhibited synoviocyte proliferation to some degree. Camptothecin had no effect on neutrophil activation but inhibited all other processes at low (nanomolar) concentrations. Plumbagin and menadione inhibited neutrophil activation, collagenases expression and angiogenesis. The other agents had little effect on neutrophil activation (except beta-laperchone) but inhibited angiogenesis and collagenase expression to a lesser degree than camptothecin. CONCLUSION: These studies support the explorative use of topoisomerase I (particularly camptothecin) and II inhibitors as potential agents for use against RA.


Subject(s)
Antirheumatic Agents/metabolism , Arthritis, Rheumatoid/immunology , Enzyme Inhibitors/metabolism , Topoisomerase I Inhibitors , Topoisomerase II Inhibitors , Animals , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Camptothecin/metabolism , Camptothecin/pharmacology , Cattle , Cell Proliferation/drug effects , Cells, Cultured , Chick Embryo , Chondrocytes/cytology , Chondrocytes/metabolism , Doxorubicin/metabolism , Doxorubicin/pharmacology , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Etoposide/metabolism , Etoposide/pharmacology , Interleukin-1/metabolism , Naphthoquinones/metabolism , Naphthoquinones/pharmacology , Neutrophils/cytology , Neutrophils/physiology , Rabbits , Synovial Membrane/cytology , Synovial Membrane/drug effects , Vitamin K 3/metabolism , Vitamin K 3/pharmacology
4.
J Orthop Surg (Hong Kong) ; 14(2): 117-21, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16914772

ABSTRACT

PURPOSE: To evaluate the effectiveness of autologous fibrin tissue adhesive (auto-FTA) in reducing blood loss during cementless total hip arthroplasty (THA). METHODS: From September 2000 to August 2001, 100 patients who predonated 400 ml of autologous blood were randomised to undergo either standard treatment with auto-FTA (auto-FTA group) or standard treatment alone (control group). The volume of postoperative blood loss and the decrease in haemoglobin level were measured. All patients were followed up for 3 years to evaluate the rate of bone ingrowth and heterotopic ossification. RESULTS: The mean postoperative blood loss was 580 ml (standard deviation [SD], 240 ml) in the auto-FTA group and 810 ml (SD, 341 ml) in the control group; the difference was significant (230 ml, p<0.001). The decrease in haemoglobin concentration was 17 g/l (SD, 11 g/l) in the auto-FTA group and 22 g/l (SD, 12 g/l) in the control group. The difference was significant (5 g/l, p=0.03). The percentage of total blood loss of >1200 ml in any single patient was significantly lower in the auto-FTA group (4%) than in the control group (20%) [p=0.01]. CONCLUSION: Auto-FTA is a safe and effective means of reducing perioperative blood loss in THA.


Subject(s)
Arthroplasty, Replacement, Hip , Fibrin Tissue Adhesive/therapeutic use , Postoperative Hemorrhage/prevention & control , Tissue Adhesives/therapeutic use , Aged , Blood Transfusion, Autologous , Female , Humans , Middle Aged , Prospective Studies
5.
Inflamm Res ; 55(4): 168-75, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16807698

ABSTRACT

OBJECTIVE: Curcumin and quercetin are antioxidant molecules with anti-proliferative, anti-inflammatory and immunosuppressive activities. The objective of this study was to investigate the inhibitory activity of these agents using four assays of inflammatory aspects of arthritis. METHODS: Crystal-induced neutrophil activation was measured by luminol-dependent chemiluminescence. Synoviocyte proliferation was measured by an MTS assay using HIG-82 rabbit synoviocytes in cell culture. Chondrocyte (cultured primary cells) expression of the matrix metalloproteinases collagenase and stromelysin was measured by Northern Blot analysis. Angiogenesis was measured using the chorioallantoic membrane of the chick embryo. RESULTS: Both agents inhibited neutrophil activation, synoviocyte proliferation and angiogenesis. Curcumin strongly inhibited collagenase and stromelysin expression at micromolar concentrations whereas quercetin had no effect in this assay. CONCLUSION: These studies suggest that curcumin and to a lesser extent quercetin may offer therapeutic potential for the treatment of crystal-induced arthritis or rheumatoid arthritis.


Subject(s)
Antioxidants/pharmacology , Arthritis/pathology , Arthritis/prevention & control , Curcumin/pharmacology , Quercetin/pharmacology , Animals , Apoptosis/drug effects , Cattle , Cell Line , Cell Proliferation/drug effects , Chondrocytes/drug effects , Chondrocytes/metabolism , Collagenases/genetics , Gene Expression Regulation/drug effects , Inflammation/prevention & control , Interleukin-1/pharmacology , Luminescent Measurements , Matrix Metalloproteinase 3/genetics , Neutrophils/cytology , Neutrophils/drug effects , Proteoglycans/genetics , Rabbits
6.
Phys Rev Lett ; 92(5): 054802, 2004 Feb 06.
Article in English | MEDLINE | ID: mdl-14995314

ABSTRACT

For high luminosity in electron-positron linear colliders, it is essential to generate low vertical emittance beams. We report on the smallest vertical emittance achieved in single-bunch-mode operation of the Accelerator Test Facility, which satisfies the requirement of the x-band linear collider. The emittances were measured with a laser-wire beam-profile monitor installed in the damping ring. The bunch length and the momentum spread of the beam were also recorded under the same conditions. The smallest vertical rms emittance measured at low intensity is 4 pm at a beam energy of 1.3 GeV, which corresponds to the normalized emittance of 1.0x1.0(-8) m. It increases by a factor of 1.5 for a bunch intensity of 10(10) electrons. The measured data agreed to the calculation of intrabeam scattering within much better than a factor of 2.

7.
Inflamm Res ; 52(1): 8-17, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12608644

ABSTRACT

OBJECTIVE AND DESIGN: To investigate the ability of various topoisomerase I and II inhibitors to reverse the pro-survival effects of calcium pyrophosphate dihydrate (CPPD) crystals on human neutrophils, thereby identifying potential agents that may promote the resolution of neutrophil accumulation typical of crystal associated inflammatory diseases. MATERIALS AND METHODS: Freshly isolated human neutrophils incubated in the presence of CPPD crystals, with or without the pro-apoptotic cytokine TNF-alpha, were pre-incubated in the presence or absence of the topoisomerase I inhibitors camptothecin, nogalamycin or beta-lapachone, or topoisomerase II inhibitors etoposide, doxorubicin or mitoxantrone. Neutrophil respiratory burst was assessed via chemiluminescence, and two quantitative methods were used for the determination of neutrophil apoptosis; cytoplasmic histone-associated-DNA fragmentation assessment, and endogenous caspase 3 substrate (Ac-DEVD-AMC) cleavage. RESULTS: Beta-lapachone and mitoxantrone effectively repressed CPPD crystal associated respiratory burst, whereas the other topoisomerase inhibitors had no inhibitory or stimulatory effect. Camptothecin and all of the topoisomerase II inhibitors induced neutrophil apoptosis, even in the presence of the CPPD crystals that normally repress TNF-alpha-induced and spontaneous apoptosis. CONCLUSIONS: These results suggest that although topoisomerase II antagonists are distinctively effective agents at reversing the pro-survival effects of crystals on neutrophils, camptothecin was unique as a topoisomerase I inhibitor in that it was significantly more effective as a pro-apoptosis inducer than the topoisomerase II poisons without affecting normal neutrophil activation responses.


Subject(s)
Apoptosis/drug effects , Calcium Pyrophosphate/pharmacology , Enzyme Inhibitors/pharmacology , Neutrophils/drug effects , Topoisomerase I Inhibitors , Topoisomerase II Inhibitors , Cell Survival/drug effects , Crystallization , Cytosol/drug effects , Cytosol/metabolism , DNA Fragmentation , Humans , In Vitro Techniques , Luminescent Measurements , Neutrophils/enzymology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/pharmacology
8.
Phys Rev Lett ; 88(19): 194801, 2002 May 13.
Article in English | MEDLINE | ID: mdl-12005637

ABSTRACT

Electron beams with the lowest, normalized transverse emittance recorded so far were produced and confirmed in single-bunch-mode operation of the Accelerator Test Facility at KEK. We established a tuning method of the damping ring which achieves a small vertical dispersion and small x-y orbit coupling. The vertical emittance was less than 1% of the horizontal emittance. At the zero-intensity limit, the vertical normalized emittance was less than 2.8 x 10(-8) rad m at beam energy 1.3 GeV. At high intensity, strong effects of intrabeam scattering were observed, which had been expected in view of the extremely high particle density due to the small transverse emittance.

9.
Dev Growth Differ ; 43(4): 383-90, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11473545

ABSTRACT

The present study examines the effects on embryogenesis of microinjecting Xenopus laevis fertilized eggs with 5-aza-2'-deoxycytidine (5-Aza-CdR), which induces hypomethylation of DNA, and 5-methyl-2'- deoxycytidine-5'-triphosphate (5-methyl-dCTP), which induces hypermethylation of DNA. Embryos injected with either one of these analogs cleaved normally until the mid-blastula stage, but underwent massive cell dissociation and stopped development at the early gastrula stage. Dissociated cells that appeared here were positive by terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-digoxigenin nick end-labeling and contained fragmented nuclei with condensed chromatin. The DNA from these cells formed a "ladder" on electrophoresis. Furthermore, the induction of cell dissociation by 5-Aza-CdR and 5-methyl-dCTP was postponed by 2-3 h by co-injection of Bcl-2 mRNA and the normal metabolite (CdR and dCTP, respectively). Using a specific antibody against 5-methyl-cytosine, we confirmed that 5-Aza-CdR induces hypomethylation, whereas 5-methyl-dCTP induces hypermethylation in X. laevis embryos before the onset of cell dissociation. Incorporation of radioactive precursors revealed that synthesis of DNA, and also RNA, is inhibited significantly in both 5-Aza-CdR-injected and 5-methyl-dCTP-injected embryos. These results show that 5-Aza-CdR and 5-methyl-dCTP are incorporated into DNA and induce apoptosis, probably through alteration of DNA methylation coupled with inhibition of DNA replication and/or transcription.


Subject(s)
Apoptosis/physiology , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacology , Embryo, Nonmammalian/physiology , Animals , DNA Fragmentation , DNA Methylation , DNA Modification Methylases/antagonists & inhibitors , Decitabine , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/ultrastructure , Female , In Situ Nick-End Labeling , Microinjections , Oocytes/physiology , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Xenopus laevis
10.
Arterioscler Thromb Vasc Biol ; 20(11): 2351-8, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11073837

ABSTRACT

We have previously shown that long-term treatment with an inflammatory cytokine from the adventitia causes the development of coronary vascular lesions, with the accumulation of macrophages. Recent studies in vitro have suggested that small G-protein Rho and its effector, Rho-kinase/ROK/ROCK, may be the key molecules for various cellular functions, including cell adhesion and movement. In this study, we examined whether adventitia-derived macrophages cause the formation of coronary vascular lesions in vivo and, if so, whether Rho-kinase is involved in the process. Porcine coronary segments from the adventitia were chronically treated with monocyte chemoattractant protein-1 alone, oxidized low density lipoprotein alone, or both. Vascular lesion formation (neointimal formation and development of vascular remodeling) was mostly enhanced at the coronary segment cotreated with monocyte chemoattractant protein-1 and oxidized low density lipoprotein, where the phosphorylation of myosin binding subunit of myosin phosphatase was increased, indicating an increased activity of Rho-kinase in vivo. Histological examination demonstrated that macrophages were accumulated at the adventitia and thereafter migrated into the vascular wall. Long-term oral treatment with fasudil, which is metabolized to a specific Rho-kinase inhibitor (hydroxyfasudil) after oral absorption, markedly inhibited the myosin binding subunit phosphorylation, the macrophage accumulation and migration, and the coronary lesion formation in vivo. These results indicate that Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in our porcine model in vivo.


Subject(s)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Coronary Vessels/enzymology , Coronary Vessels/pathology , Macrophages/enzymology , Macrophages/pathology , Protein Serine-Threonine Kinases/physiology , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/administration & dosage , Administration, Oral , Animals , Cell Movement/drug effects , Cell Movement/immunology , Coronary Vessels/drug effects , Coronary Vessels/physiopathology , Enzyme Activation/drug effects , Enzyme Inhibitors/administration & dosage , Humans , Intracellular Signaling Peptides and Proteins , Macrophages/drug effects , Male , Neovascularization, Pathologic/enzymology , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Neovascularization, Pathologic/prevention & control , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/metabolism , Swine , rho-Associated Kinases
11.
Int J Dev Biol ; 44(5): 507-10, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11032186

ABSTRACT

Overexpression of S-adenosylmethionine decarboxylase (SAMDC) mRNA in 1- and 2-cell stage Xenopus embryos induces cell autonomous dissociation at the late blastula stage and developmental arrest at the early gastrula stage. The induction of cell dissociation took place "punctually" at the late blastula stage in the SAMDC-overexpressing cells, irrespective of the stage of the microinjection of SAMDC mRNA. When we examined the cells undergoing the dissociation, we found that they were TUNEL-positive and contained fragmented nuclei with condensed chromatin and fragmented DNA. Furthermore, by injecting Xenopus Bcl-2 mRNA together with SAMDC mRNA, we showed that SAMDC-overexpressing embryos are rescued completely by Bcl-2 and becometadpoles. These results indicatethat cell dissociation induced by SAMDC overexpression is due to apoptotic cell death. Since the level of S-adenosylmethionine (SAM) is greatly reduced in SAMDC-overexpressing embryos and this induces inhibition of protein synthesis accompanied by the inhibition of DNA and RNA syntheses, we conclude that deficiency in SAM induced by SAMDC overexpression activates the maternal program of apoptosis in Xenopus embryos at the late blastula stage, but not before. We propose that this mechanism serves as a surveillance mechanism to check and eliminate cells physiologically damaged during the cleavage stage.


Subject(s)
Adenosylmethionine Decarboxylase/metabolism , Embryo, Nonmammalian/metabolism , Animals , Blastocyst/metabolism , DNA/metabolism , DNA, Complementary/metabolism , Electrophoresis, Agar Gel , Embryo, Nonmammalian/ultrastructure , In Situ Nick-End Labeling , Microinjections , Microscopy, Electron , Plasmids/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Messenger/metabolism , S-Adenosylmethionine/metabolism , Time Factors , Xenopus
12.
Virchows Arch ; 436(6): 622-7, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10917179

ABSTRACT

Primary vaginal adenocarcinoma unrelated to in utero exposure to diethylstilbestrol (DES) is very uncommon. We report a case of 65-year-old Japanese woman who presented with primary adenocarcinoma in the anterior wall of the vagina, where the left ureter-like metanephric duct remnant abnormally terminated. Histological examination in serial sections revealed the direct connection between the carcinoma and the metanephric duct remnant. Moreover, the remnant epithelium showed varying degrees of dysplastic changes, including carcinoma in situ in close proximity to the carcinoma. This patient also had a bicornate uterus and left renal aplasia. To our knowledge, this is the first reported case of a primary vaginal adenocarcinoma arising from the metanephric duct remnant. Although the precise mechanism involved in carcinogenesis in this clinicopathological setting remains unknown, adenocarcinoma should be included in the differential diagnosis of vaginal tumors in patients with renal aplasia and/or an ectopic termination of the ureter or metanephric duct remnant, especially when the tumor is in the anterior wall.


Subject(s)
Adenocarcinoma/pathology , Choristoma/pathology , Ureter , Vaginal Diseases/pathology , Vaginal Neoplasms/pathology , Adenocarcinoma/surgery , Aged , Choristoma/surgery , Female , Humans , Hysterectomy , Immunohistochemistry , Immunophenotyping , Mesonephros/abnormalities , Mesonephros/surgery , Uterus/abnormalities , Uterus/surgery , Vaginal Diseases/surgery , Vaginal Neoplasms/surgery
13.
J Atheroscler Thromb ; 6(2): 42-8, 2000.
Article in English | MEDLINE | ID: mdl-10872613

ABSTRACT

To clarify whether acute medial necrosis of the aorta induces aneurysms and intimal thickening at a later stage, we first attempted to induce acute aortic medial necrosis in 47 normal rabbits by the administration of Russell's viper venom intraperitoneally and of angiotensin II intravenously as used in a previous study and then followed the rabbits for 1 and 2 months respectively. As a control, 18 adult normal rabbits were used. Six control and 20 treated rabbits were sacrificed after aortagraphy at the end of one month, while the remaining 12 control and 27 treated rabbits were sacrificed at the end of 2 months. We evaluated the aortic lesions by gross observations and both light and electron microscopic examinations. In addition, at the end of one month, aortagraphy was performed to measure the luminal diameter of the aorta of the 6 control and 20 treated rabbits. We macroscopically found the saccular lesions to be surrounded by small crater like lesions mainly at the thoracic aortas in 18 out of 47 treated rabbits. These lesions consisted of the necrosis and calcification of the aortic media and the destruction of the elastic fiber along with intimal thickening. However, no aneurysmal dilatation was found in the aortagraphy findings. We thus conclude that acute medial necrosis produced saccular and crater like lesions but these lesions were not confirmed by aortagraphy.


Subject(s)
Aorta/pathology , Aortic Aneurysm/etiology , Aortic Aneurysm/pathology , Animals , Male , Necrosis , Rabbits , Tunica Media/pathology
14.
Comp Biochem Physiol B Biochem Mol Biol ; 126(2): 149-55, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10874162

ABSTRACT

When we studied polyamine metabolism in Xenopus embryos, we cloned the cDNA for Xenopus S-adenosylmethionine decarboxylase (SAMDC), which converts SAM (S-adenosylmethionine), the methyl donor, into decarboxylated SAM (dcSAM), the aminopropyl donor, and microinjected its in vitro transcribed mRNA into Xenopus fertilized eggs. We found here that the mRNA injection induces a SAM deficient state in early embryos due to over-function of the overexpressed SAMDC, which in turn induces inhibition of protein synthesis. Such embryos developed quite normally until blastula stage, but stopped development at the early gastrula stage, due to induction of massive cell dissociation and cell autolysis, irrespective of the dosage and stage of the mRNA injection. We found that the dissociated cells were TUNEL-positive, contained fragmented nuclei with ladder-forming DNA, and furthermore, rescued completely by coinjection of Bcl-2 mRNA. Thus, overexpression of SAMDC in Xenopus embryos appeared to switch on apoptotic program, probably via inhibition of protein synthesis. Here, we briefly review our results together with those reported from other laboratories. After discussing the general importance of this newly discovered apoptotic program, we propose that the maternal program of apoptosis serves as a surveillance mechanism to eliminate metabolically severely-damaged cells and functions as a 'fail-safe' mechanism for normal development in Xenopus embryos.


Subject(s)
Adenosylmethionine Decarboxylase/metabolism , Apoptosis , Blastocyst/physiology , Xenopus/embryology , Adenosylmethionine Decarboxylase/genetics , Animals , Blastocyst/ultrastructure , Microinjections , Models, Biological , RNA, Messenger/genetics , RNA, Messenger/metabolism , Time Factors
15.
J Am Coll Cardiol ; 35(4): 1040-7, 2000 Mar 15.
Article in English | MEDLINE | ID: mdl-10732906

ABSTRACT

OBJECTIVE: This study was designed to examine whether or not adenovirus-mediated gene transfer of C-type natriuretic peptide (CNP) can prevent coronary restenotic changes after balloon injury in pigs in vivo. BACKGROUND: Gene therapy to prevent restenosis after percutaneous transluminal coronary angioplasty (PTCA) might be useful but requires a method applicable for in vivo gene delivery into the coronary artery as well as the efficient vector encoding a potent antiproliferative substance. We tested whether the adenovirus-mediated gene transfer of CNP by use of an infiltrator angioplasty balloon catheter (IABC) might prevent the coronary restenotic changes after balloon injury. METHODS: Balloon angioplasty was performed in the left anterior descending and the left circumflex coronary artery in pigs. Immediately after the balloon injury, adenovirus solution encoding either CNP (AdCACNP) or beta-galactosidase (AdCALacZ) gene was injected with IABC into the balloon-injured coronary segments. Expression of CNP was assessed by immunohistochemical staining and cyclic guanosine 3',5'-monophosphate (cGMP) measurement. Coronary restenotic changes were evaluated by both angiographic and histological examinations. RESULTS: CNP was highly expressed in the media and the adventitia of the coronary artery at the AdCACNP-transfected but not at the AdCALacZ-transfected segment. In the AdCALacZ-transfected segment, vascular cGMP levels tended to be reduced as compared with the untreated segment, whereas in the AdCACNP-transfected segment, vascular cGMP levels were restored. Angiographic coronary stenosis was significantly less at the AdCACNP-transfected than at the AdCALacZ-transfected segment. Histological examination revealed that this was achieved primarily by the marked inhibition of the geometric remodeling of the coronary artery by the CNP gene transfer. CONCLUSIONS: Adenovirus-mediated CNP gene transfer with the IABC system may be a useful gene therapy to prevent restenosis after PTCA in vivo.


Subject(s)
Adenoviridae/genetics , Angioplasty, Balloon, Coronary , Coronary Circulation/genetics , Coronary Disease/therapy , Gene Transfer Techniques , Genetic Therapy , Natriuretic Peptide, C-Type/genetics , Animals , Coronary Angiography , Coronary Disease/genetics , Coronary Disease/pathology , Coronary Vessels/injuries , Coronary Vessels/pathology , Gene Expression Regulation/physiology , Recurrence , Swine
16.
Circulation ; 101(11): 1319-23, 2000 Mar 21.
Article in English | MEDLINE | ID: mdl-10725293

ABSTRACT

BACKGROUND: We recently demonstrated that the Rho-kinase-mediated pathway plays an important role for coronary artery spasm in our porcine model with interleukin-1beta (IL-1beta). In this study, we examined whether or not Rho-kinase is upregulated at the spastic site and if so, how it induces vascular smooth muscle hypercontraction. METHODS AND RESULTS: Segments of the left porcine coronary artery were chronically treated from the adventitia with IL-1beta-bound microbeads. Two weeks after the operation, as reported previously, intracoronary serotonin repeatedly induced coronary hypercontractions at the IL-1beta-treated site both in vivo and in vitro, which were markedly inhibited by Y-27632, one of the specific inhibitors of Rho-kinase. Reverse transcription-polymerase chain reaction analysis demonstrated that the expression of Rho-kinase mRNA was significantly increased in the spastic compared with the control segment. Western blot analysis showed that during the serotonin-induced contractions, the extent of phosphorylation of the myosin-binding subunit of myosin phosphatase (MBS), one of the major substrates of Rho-kinase, was significantly greater in the spastic than in the control segment and that the increase in MBS phosphorylations was also markedly inhibited by Y-27632. There was a highly significant correlation between the extent of MBS phosphorylations and that of contractions. CONCLUSIONS: These results indicate that Rho-kinase is upregulated at the spastic site and plays a key role in inducing vascular smooth muscle hypercontraction by inhibiting myosin phosphatase through the phosphorylation of MBS in our porcine model.


Subject(s)
Coronary Vasospasm/chemically induced , Coronary Vasospasm/physiopathology , Interleukin-1 , Phosphoprotein Phosphatases/antagonists & inhibitors , Protein Serine-Threonine Kinases/physiology , Animals , Interleukin-1/administration & dosage , Intracellular Signaling Peptides and Proteins , Isoenzymes/metabolism , Microspheres , Myosin-Light-Chain Phosphatase , Myosins/metabolism , Phosphoprotein Phosphatases/metabolism , Phosphorylation , Reverse Transcriptase Polymerase Chain Reaction , Swine , Up-Regulation , rho-Associated Kinases
17.
J Cardiovasc Pharmacol ; 35(2): 294-301, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10672864

ABSTRACT

Serotonin is one of the most important vasoactive substances and has been implicated in the pathogenesis of coronary artery spasm and of acute coronary syndrome. We have recently demonstrated that local and long-term treatment with interleukin-1beta(IL-1beta) causes coronary arteriosclerotic changes and hyperconstrictive responses to serotonin in pigs in vivo. However, it remains to be examined which serotonergic (5-HT) receptor subtype mediates coronary spasm and whether alterations in serotonergic receptors are involved in the abnormality. In this study, we examined the inhibitory effect of sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, on the serotonin-induced coronary spasm as well as the possible alterations of serotonergic receptors in our porcine model. A segment of the porcine coronary artery was carefully dissected and aseptically wrapped with cotton mesh absorbing IL-1beta-bound microbeads from the adventitia. Two weeks after the procedure, angiographic study was performed, followed by binding assay for 5-HT1B and 5-HT2A serotonergic receptors and reverse transcription-polymerase chain reaction (RT-PCR) analysis for mRNA of those receptors. Angiographic study showed coronary vasospastic responses to serotonin at the IL-1beta-treated site. Sarpogrelate dose-dependently inhibited the serotonin-induced coronary spasm, but it did not affect the prostaglandin F2alpha-induced vasoconstriction. Radiolabeled receptor-binding assay showed that receptor affinity or receptor number of the 5-HT1B, or 5-HT2A receptors did not differ significantly between the spastic and the control sites. Furthermore, RT-PCR analysis showed that the expression of neither 5-HT2A nor 5-HT1B receptor mRNA was significantly altered at the spastic site. These results indicate that serotonin-induced coronary spasm is mediated primarily by 5-HT2A receptor in our porcine model, although the 5-HT2A receptor was not up-regulated, suggesting that alteration in the signal-transduction pathway for vascular smooth muscle contraction beyond the 5-HT2A receptor plays a primary role in the pathogenesis of coronary spasm in our porcine model.


Subject(s)
Coronary Vasospasm/prevention & control , Muscle, Smooth, Vascular/drug effects , Receptors, Serotonin/drug effects , Serotonin Antagonists/pharmacology , Serotonin/pharmacology , Succinates/pharmacology , Angiography , Animals , Base Sequence , Coronary Vasospasm/chemically induced , Dinoprost/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , In Vitro Techniques , Interleukin-1/pharmacology , Male , Molecular Sequence Data , Muscle Contraction/drug effects , Protein Binding/drug effects , RNA, Messenger/analysis , Receptors, Serotonin/classification , Reverse Transcriptase Polymerase Chain Reaction , Swine , Up-Regulation/drug effects , Vasoconstrictor Agents/pharmacology
18.
Circulation ; 100(13): 1432-7, 1999 Sep 28.
Article in English | MEDLINE | ID: mdl-10500045

ABSTRACT

BACKGROUND: The question of whether or not endothelial vasodilator function in the spastic coronary artery is preserved is still controversial. We recently developed a porcine model in which long-term and local treatment with interleukin-1beta (IL-1beta) from the adventitial site causes coronary arteriosclerotic changes and vasospastic responses to autacoids. The aim of this study was to examine the endothelial vasodilator function in our new porcine model of the spasm both in vivo and in vitro. METHODS AND RESULTS: A segment of the porcine coronary artery was aseptically wrapped with cotton mesh that held absorbed IL-1beta-bound microbeads. Two weeks after the procedure, intracoronary administration of serotonin caused coronary vasospasm at the IL-1beta-treated site (n = 10). Coronary vasodilatation to bradykinin, substance P, or an increase in coronary blood flow was preserved at the spastic site. Vasodilator responses to 3-morpholinosydnonimine (an NO donor) and nitroglycerin also were comparable between the 2 sites. The vasoconstricting response to N(G)-monomethyl-L-arginine and the extent of the augmentation of the serotonin-induced vasoconstriction were comparable between the 2 sites. Organ chamber experiments showed that endothelium-dependent relaxations to bradykinin, the calcium ionophore A23187, and even the vasospastic agonist serotonin were preserved at the spastic site, whereas contractions to serotonin were augmented at the spastic site regardless of the presence or absence of the endothelium (n = 6). Endothelium-independent relaxations to sodium nitroprusside were also preserved at the spastic site. CONCLUSIONS: These results indicate that endothelial vasodilator function is preserved at the spastic site and that the spasm is caused primarily by smooth muscle hypercontraction in our porcine model.


Subject(s)
Coronary Vasospasm/physiopathology , Endothelium, Vascular/physiopathology , Muscle, Smooth, Vascular/physiopathology , Myocarditis/physiopathology , Vasodilation , Animals , Coronary Vasospasm/chemically induced , Endothelium, Vascular/drug effects , In Vitro Techniques , Interleukin-1 , Male , Muscle, Smooth, Vascular/drug effects , Serotonin , Swine , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology
20.
J Am Coll Cardiol ; 32(3): 780-6, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9741527

ABSTRACT

OBJECTIVES: This study was designed to examine whether or not intramural delivery of ST638 (a specific tyrosine kinase inhibitor) with biodegradable stent can suppress the restenotic changes of the coronary artery in vivo. BACKGROUND: Clinical and animal studies demonstrated that restenosis after coronary intervention results from a combined effect of neointimal formation and geometric remodeling (decrease in total cross-sectional area). Thus, the most effective strategy to prevent the restenosis appears to inhibit both the neointimal formation and geometric remodeling by antiproliferative agent and stent, respectively. We have previously shown that ST638 markedly suppresses the restenotic changes of the porcine coronary artery when applied from the adventitial site. METHODS: A poly-L-lactic acid biodegradable stent was coated with either ST638 (0.8 mg) or equimolar of its inactive metabolite, ST494. A pair of these stents were implanted alternatively in the left anterior descending or circumflex coronary artery in pigs (n=6). Three weeks after the procedure, coronary stenosis was assessed by angiography followed by histological examination. RESULTS: Coronary stenosis was significantly less at the ST638 stent site than at the ST494 stent site (47+/-5% vs. 25+/-4%, p < 0.01). Histological examination also showed that the extent of neointimal formation and that of geometric remodeling were significantly less at the ST638 stent site than at the ST494 stent site (p < 0.05). CONCLUSIONS: These results indicate that intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent overcomes the proliferative stimuli caused by balloon injury, the stent itself, and the drug coating on the stent, resulting in the suppression of the restenotic changes of the coronary artery in vivo. This strategy might also be useful in the clinical setting in humans.


Subject(s)
Cinnamates/administration & dosage , Coronary Disease/therapy , Coronary Vessels/drug effects , Enzyme Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/administration & dosage , Protein-Tyrosine Kinases/antagonists & inhibitors , Stents , Sulfides/administration & dosage , Animals , Coronary Disease/pathology , Coronary Vessels/pathology , Drug Implants , Equipment Design , Lactic Acid , Male , Polyesters , Polymers , Recurrence , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...